VSIR: A Potential Drug Target for Cancer and Other Diseases (G64115)

Target Name: VSIR

NCBI ID: G64115

VSIR

VSIR: A Potential Drug Target for Cancer and Other Diseases

Vistra (VSIR) is a protein that is expressed in the human placenta and has been shown to play a role in the development and progression of various diseases, including cancer. VSIR has also been identified as a potential drug target and biomarker. In this article , we will explore the biology and potential drug targeting of VSIR.

Background

VSIR is a 21-kDa protein that is expressed in the human placenta and has been shown to be involved in various physiological processes, including cell adhesion, migration, and invasion. VSIR has also been shown to play a role in the development and progression of various diseases, including cancer.

VSIR is a member of the integrin receptor family, which includes proteins that are involved in cell-cell and cell-extracellular matrix interactions. VSIR has been shown to interact with several different extracellular matrix (ECM) components, including ECM-derived growth factors (GFs) and ECM-derived cytokines (TFs). VSIR has also been shown to play a role in the regulation of cell adhesion and migration, as well as the regulation of the Wnt signaling pathway.

VSIR has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. VSIR has also been shown to play a role in the regulation of angiogenesis by promoting the migration of progenitor cells to the site of an injury or disease.

Potential Drug Targeting

VSIR has been identified as a potential drug target due to its involvement in the development and progression of various diseases, including cancer. VSIR has also been shown to play a role in the regulation of cell adhesion, migration, and angiogenesis, which makes it an attractive target for small molecules.

VSIR has been shown to be involved in the regulation of cell adhesion by interacting with several different ECM components. VSIR has been shown to interact with ECM-derived growth factors (GFs), such as FGF-1 and TGF-2, as well as with ECM-derived cytokines (TFs), such as PDGF-2 and NF-kappa-B. VSIR has also been shown to play a role in the regulation of cell migration by interacting with several different cytoskeleton components, including tubulin (MAPK) and actinin.

VSIR has also been shown to be involved in the regulation of angiogenesis by promoting the migration of progenitor cells to the site of an injury or disease. VSIR has also been shown to play a role in the regulation of angiogenesis by interacting with several different factors, including theNotch signaling pathway and the Wnt signaling pathway.

VSIR has also been shown to play a role in the regulation of cell apoptosis, which is the process by which cells die as a result of external or internal stressors. VSIR has also been shown to play a role in the regulation of cell apoptosis by interacting with several different factors, including Bcl-2 and p53.

VSIR has also been shown to play a role in the regulation of inflammation, which is a complex process that is involved in the immune response and the regulation of tissue repair. VSIR has also been shown to play a role in the regulation of inflammation by interacting with several different factors, including nuclear factor kappa B (NFKB) and the chemokine profile (CXCL1).

Conclusion

VSIR is a protein that is expressed in the human placenta and has been shown to play a role in various physiological processes, including cell adhesion, migration, and invasion. VSIR is also a member of the integrin receptor

Protein Name: V-set Immunoregulatory Receptor

Functions: Immunoregulatory receptor which inhibits the T-cell response (PubMed:24691993). May promote differentiation of embryonic stem cells, by inhibiting BMP4 signaling (By similarity). May stimulate MMP14-mediated MMP2 activation (PubMed:20666777)

The "VSIR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VSIR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets